InvestorsHub Logo
Followers 0
Posts 22
Boards Moderated 0
Alias Born 01/01/2021

Re: tripmcneely post# 27494

Thursday, 07/15/2021 4:15:23 PM

Thursday, July 15, 2021 4:15:23 PM

Post# of 36642
There’s going to be multiple oral covid therapeutics. The data will be the differentiator and drive market value.

We haven’t seen data yet, but the science behind bucillamine is superior to any other phase 3 drug that’s close behind us.